Public Company News

HONEYWELL SURVEY: 100% OF SOUTHEAST ASIA OFFICE WORKERS PLACE IMPORTANCE ON BEING INFORMED OF THEIR BUILDING'S AIR QUALITY

SINGAPORE and KUALA LUMPUR, Malaysia and MANILA, Philippines, Feb. 22, 2022 /PRNewswire/ -- In a survey of office workers inSoutheast Asia, all (100%) respondents working in an office building report it is important for their employer or building manager to keep them informed of their facility...

2022-02-22 10:00 6106

TAL Education Group Announces Unaudited Financial Results for the Third Fiscal Quarter Ended November 30, 2021

BEIJING, Feb. 21, 2022 /PRNewswire/ -- TAL Education Group (NYSE: TAL) ("TAL" or the "Company"), a smart learning solutions provider inChina, today announced its unaudited financial results for the third quarter of fiscal year 2022 ended November 30, 2021.   Highlights for the Third Quarter of Fi...

2022-02-22 07:00 4436

Daewoong Pharmaceutical Posts Record Annual Revenue in 2021, with Export Growth of Nabota and New Drug Development

* Recorded operating profit KRW 88.9 billion and net profit KRW 31.6 billion in 2021 with the outcome of its relentless focus on R&D * Attributed to export upswing of Nabota, KRW 1.1 trillion overseas technology transfer of Fexuclue tablets, and growth of highly profitable ETC drugs SEOUL, So...

2022-02-21 22:00 2927

HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer

SEOUL, South Korea, Feb. 21, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment ofAlmira Chabi, M.D. as Chief Medical Officer and Chief Development Officer at HanAll Pharmaceutical International (HPI), a U.S. entity wholly owned by HanAll Biopharma, to strengt...

2022-02-21 22:00 2742

Adlai Nortye Announces Publication of Preclinical Research of AN3025 (anti-hTNFR2)in Frontiers in Immunology

NORTH BRUNSWICK, N.J. and HANGZHOU, China, Feb. 21, 2022 /PRNewswire/ -- recently -- Adlai Nortye Ltd. ("Adlai Nortye"), a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies, announced the publication of preclinical research of AN3025 (anti-hTNFR2)...

2022-02-21 21:00 2708

Harbour BioMed Announces IND Approval for Next-Gen Anti-TSLP Fully Human Monoclonal Antibody

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Feb. 21, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that China National Medical Products Administration (NMPA) had approved its investigational new drug (IND) application for HBM9378 (or SKB378 as referred to ...

2022-02-21 20:29 2849

LAIX Inc. Announces Plan to Implement ADS Ratio Change

SHANGHAI, Feb. 21, 2022 /PRNewswire/ -- LAIX Inc. ("LAIX" or the "Company") (NYSE: LAIX), an artificial intelligence (AI) company inChina that creates and delivers products and services to popularize English learning, today announced that it plans to change the ratio of its American Depositary Sh...

2022-02-21 20:00 5144

Puxin Limited Announces Regain Compliance with NYSE Minimum Price Requirement

BEIJING, Feb. 21, 2022 /PRNewswire/ -- Puxin Limited (NYSE: NEW) ("Puxin" or the "Company"), a private educational services provider inChina, today announced that based on a notification letter it received onFebruary 18, 2022 from the New York Stock Exchange ("NYSE"), the Company has regained com...

2022-02-21 19:03 4751

Weibo Corporation to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 3, 2022

BEIJING, Feb. 21, 2022 /PRNewswire/ -- Weibo Corporation (NASDAQ: WB and HKEX: 9898), a leading social media for people to create, share and discover content, will announce its unaudited financial results for the fourth quarter and fiscal year 2021 before the U.S. market opens onThursday, March 3...

2022-02-21 18:30 4614

XCMG Pushes for Carbon Neutrality within Its Operating Boundaries by 2049

SHANGHAI, Feb. 21, 2022 /PRNewswire/ -- XCMG (SHE:000425) releases a program of action (PoA) for peak carbon and carbon neutrality, detailing planning, implementation and actual safeguard measures of sustainable transformation paths — including low-carbon transformation of energy consumption stru...

2022-02-21 17:23 3130

EP&T Global Secures New Multi-Year Contracts in UK Market

Highlights * EP&T Global Limited (EP&T) signs a multi-year agreement with a fund affiliated with MCAP Global Finance (UK) LLP, the European subsidiary ofNew York -headquartered Marathon Asset Management LP with an Annual Contract Value (ACV) ofA$0.55m and a Total Contract Value (TCV) in excess ...

2022-02-21 16:34 2265

Midea Reveals Next-Gen S8+ Robot Vacuum Cleaner to Refresh Homes this Winter

SUZHOU, China, Feb. 21, 2022 /PRNewswire/ -- Midea Robozone Technology has announced the launch of the Midea S8+ intelligent auto-dust-collection robot, which liberates users' hands for up to 30 days with its automatic dust collection station. Midea Robozone Technology is a subsidiary of Midea Gr...

2022-02-21 16:00 2900

DL Holdings and YF Life Announced Strategic Partnership to Accelerate the Development of Family Office and Asset Management Business

HONG KONG, Feb. 21, 2022 /PRNewswire/ -- On 16 February 2022, DL Holdings Group Limited ("DL Holdings" or the "Company" and its subsidiaries (together, the "Group"), Stock Code: 1709)announced that it will engage in a comprehensive partnership with YF Life in the next three years. YF Life Innovat...

2022-02-21 13:23 4892

CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China

TIANJIN, China, Feb. 21, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) ("Ad5-nCoV", trade name: Convidecia™) has been approved by the Joint Prevention and Control Mechanism ...

2022-02-21 08:05 4142

LG Energy Solution's New Chief Digital Officer to Lead Digital Transformation of Battery Manufacturing Unit

SEOUL, South Korea, Feb. 20, 2022 /PRNewswire/ -- LG Energy Solution (LGES; KRX: 373220) today announced it welcomed Dr.Peter Kyungsuk Pyun as the newly created position of Chief Digital Officer, CDO, as the company ramps up efforts to digitally transform its entire global facilities into data-ce...

2022-02-21 08:00 2760

Innovent Announces First Patient Dosing of Universal "Modular" CAR-T Cell product IBI345

SAN FRANCISCO and SUZHOU, China, Feb. 21, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2022-02-21 08:00 4485

Meihua International Medical Technologies Co., Ltd. Announces Closing of $39.4 Million Initial Public Offering

YANGZHOU, China, Feb. 18, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today announced the closing of...

2022-02-19 05:30 7186

OliPass Announces Commencement of Dosing in Phase 2a Trial for Pain Killer OLP-1002

SEOUL, South Korea, Feb. 18, 2022 /PRNewswire/ -- OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced that the dosing of pain killer OLP-1002 commenced for a Phase 2a trial in osteoarthritis patients with pain. The Phase 2a study was appr...

2022-02-18 23:00 3798

Yili Group's Outlook Upgraded to Stable and Rating Affirmed at "A-" by S&P Global

* Yili's commitment to maintaining low leverage while it pursues growth supports the upgrade of its outlook to stable. * Yili could achieve its 2025 growth target through organic growth alone. HUHHOT,China, Feb. 18, 2022 /PRNewswire/ -- S&P Global Ratings announced it has revised its rating o...

2022-02-18 22:28 7674

Keymed Bio Joins Hang Seng Family of Indexes

HONG KONG, Feb. 18, 2022 /PRNewswire/ --  According to the quarterly review results of Hang Seng Family of Indexes, Keymed Biosciences Inc. (2162. HK) was included a constituent stock of: * Hang Seng Composite Index; * Hang Seng Small Cap (Investable) Index; * Hang Seng Stock Connect Hong K...

2022-02-18 22:10 7181